SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-018236
Filing Date
2023-04-13
Accepted
2023-04-13 16:30:52
Documents
20

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20007011x1_def14a.htm   iXBRL DEF 14A 1746506
6 ny20007011x1_barchart01.jpg GRAPHIC 147577
7 ny20007011x1_barchart02.jpg GRAPHIC 132662
8 ny20007011x1_barchart03.jpg GRAPHIC 141187
9 ny20007011x1_pc1.jpg GRAPHIC 690844
10 ny20007011x1_pc2.jpg GRAPHIC 887202
11 sig_kellymacdonald.jpg GRAPHIC 13057
  Complete submission text file 0001140361-23-018236.txt   7935604

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dvax-20230526.xsd EX-101.SCH 6365
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20230526_def.xml EX-101.DEF 6695
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20230526_lab.xml EX-101.LAB 34368
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20230526_pre.xml EX-101.PRE 32642
14 EXTRACTED XBRL INSTANCE DOCUMENT ny20007011x1_def14a_htm.xml XML 332686
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34207 | Film No.: 23818716
SIC: 2834 Pharmaceutical Preparations